Current Report Filing (8-k)
July 10 2017 - 8:27AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 3, 2017
|
|
|
|
|
|
|
|
REAC GROUP, INC.
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Florida
|
|
000-54845
|
|
59-3800845
|
(state or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
|
|
|
|
|
|
8878 Covenant Avenue, Suite 209
Pittsburgh, PA
|
|
15237
|
(address of principal executive offices)
|
|
(zip code)
|
|
|
(724) 656-8886
|
(registrants telephone number, including area code)
|
|
|
|
(former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
1
Section 1Registrants Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On July 5, 2017 (the Closing Date), REAC Group, Inc. (the Company) entered into a Securities Purchase Agreement (SPA) and related documents (the Financing) with an institutional accredited investor (Investor). On the Closing Date, the Company issued to Investor a Convertible Promissory Note (the Note) in the principal amount of $175,000, in exchange for payment by Investor of $157,500. The principal sum of the Note reflects the amount invested, plus a $17,500 Original Issue Discount (OID). There is no material relationship between the Company or its affiliates and the Investor and the Company paid no commissions or other placement agent fees. The SPA and the Note are collectively referred to herein as the Transaction Documents.
The Note is convertible into shares of the Companys common stock at a conversion price equal to 50% multiplied by the Market Price (as such term is defined in the Note). The Company may prepay the Note any time up to the 180
th
day after issuance of the note by payment to Investor of 135% (if within 90 days of closing) or 150% (if during the 91
st
through 180
th
day after closing) of the principal, interest and other amounts then due under the Note.
Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to ten (10) times the number of shares issuable on conversion of the Note.
The foregoing summary description of the terms of the Transaction Documents may not contain all information that is of interest to the reader. For further information regarding the terms of the Transaction Documents, reference is made to such Transaction Documents, which are filed hereto as Exhibit 10.1, and are incorporated herein by this reference.
Section 2Financial Information
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of Registrant
The information provided above in Item 1.01
Entry into a Material Definitive Agreement of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.
Section 3Securities and Trading Markets
Item 3.02 Unregistered Sales of Equity Securities
(a)
July 7, 2017 Financing
The information provided above in Item 1.01
Entry into a Material Definitive Agreement of this Current Report on Form 8-K is incorporated by reference into this Item 3.02(a).
The issuance of the Notes and the issuance of the shares of the Companys common stock upon conversion of the Notes in connection with the Financing is exempt from registration under the Securities Act of 1933, as amended (the Act), in reliance on exemptions from the registration requirements of the Act in transactions not involved in a public offering pursuant to Rule 506(b) of Regulation D, as promulgated by the Securities and Exchange Commission under the Act.
(b)
July 3, 2017 Issuance
On July 3, 2017, REAC GROUP Inc. (the Company) issued 30,000,000 shares of its common stock to the sole Director, Robert DeAngelis, as a performance bonus pursuant to his employment agreement. The shares were valued at $0.035, which was the average price for which the Company stock sold during the ten (10) trading days ending June 30, 2017, as reported on OTCMarkets website.
The issuance of the shares described above was made without registration under the Securities Act of 1933, as amended (the Act), in reliance on the exemptions provided by Section 4(a)(2) of the Act and Regulation D under the Act. No advertising or general solicitation was made in connection with the sale and issuance of the Companys common stock.
2
Section 9
Financial Statements and Exhibits.
Item 9.01. Financial Statements and Exhibits.
d.
Exhibits
|
|
|
|
NUMBER
|
EXHIBIT
|
10.1
|
Stock Purchase Agreement, dated July 5, 2017
|
10.2
|
Convertible Promissory Note, dated July 5, 2017
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
REAC GROUP, INC.
|
|
|
|
|
July 10, 2017
|
/s/ Robert DeAngelis
|
|
Robert DeAngelis
|
|
Chief Executive Officer
|
3
REAC (CE) (USOTC:REAC)
Historical Stock Chart
From Jan 2025 to Feb 2025
REAC (CE) (USOTC:REAC)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about REAC Group Inc (CE) (OTCMarkets): 0 recent articles
More Reac Group, Inc. News Articles